Dental Practice Valuation: The Complete Guide for Practice Owners in 2026

Understanding what your dental practice is worth — and more importantly, what a buyer will actually pay for it — requires more than a single formula. Dental practice valuation is a function of financial performance, operational quality, market conditions, and buyer type. The number your accountant produces and the number a PE-backed DSO offers can differ significantly — and understanding why is the difference between a transaction that meets your goals and one that doesn't.

This guide covers every valuation method used in dental practice transactions today, the specific factors that move multiples up or down, what different buyer types actually pay, and how to maximize your valuation before going to market.

At Viturtal Consulting, we have advised on dental practice transactions ranging from single-location sales to national DSO platform strategies involving hundreds of locations. The frameworks in this guide reflect real transaction data and direct engagement experience — not textbook theory.

The Three Primary Dental Practice Valuation Methods

1. EBITDA Multiple — The Primary Method for DSO and PE Transactions

For practices generating $500,000 or more in EBITDA, the EBITDA multiple method is the dominant approach used by DSOs, private equity sponsors, and institutional buyers.

EBITDA — Earnings Before Interest, Taxes, Depreciation, and Amortization — represents the cash-generating capacity of the practice independent of its financing structure or ownership-specific tax decisions. PE buyers use EBITDA because it allows apples-to-apples comparison across practices with different debt structures, tax strategies, and owner compensation models.

The formula is straightforward:

Practice Value = EBITDA × Multiple

In today's market, dental practice EBITDA multiples range from 4x to 9x depending on practice size, geography, growth trajectory, payer mix, and competitive dynamics in the local market. DSO platform acquisitions — where the practice is being acquired as part of a larger portfolio strategy — typically command multiples in the 5x to 8x range. Top-performing single locations in high-growth markets with clean financials have transacted above 9x.

What PE buyers actually pay vs. what they offer:

PE-backed DSOs will recast your EBITDA using their own methodology before finalizing an offer. Recasting adds back legitimate owner-specific expenses — personal vehicle, personal insurance, above-market owner compensation — that inflate expenses on the P&L but aren't genuine operating costs of the practice. The recast EBITDA is almost always higher than what appears on your tax return.

If you don't know your recast EBITDA before entering negotiations, the buyer will. That information asymmetry directly affects your negotiating position.

2. Revenue Multiple — Common for Smaller Practices and Initial Estimates

For practices below $500,000 in EBITDA, or for preliminary valuation conversations, revenue multiples are commonly used. The formula:

Practice Value = Annual Collections × Multiple

Revenue multiples in dental transactions typically range from 0.6x to 1.0x annual collections for general dentistry practices, with specialty practices commanding higher multiples. A general dentistry practice collecting $1.5M annually might be valued between $900,000 and $1.5M using this method.

The limitation of revenue multiples is that they don't account for profitability — a practice collecting $2M with 70% overhead is worth significantly less than a practice collecting $2M with 55% overhead, but a revenue multiple alone doesn't capture that difference.

Revenue multiples are most useful as a quick sanity check or starting point, not as the definitive valuation method for a transaction.

3. Net Asset Value — Relevant for Asset-Heavy Practices

Net asset value — the fair market value of the practice's tangible assets minus liabilities — is used primarily in specific situations: practices with minimal goodwill, practices where clinical equipment is the primary value driver, or as a floor value when income-based methods produce very low results.

For most general dentistry practices, goodwill (the intangible value of the patient base, brand, and established revenue stream) far exceeds the value of tangible assets. Net asset value alone significantly undervalues a well-run practice and should not be the basis for a transaction involving a going concern.

What Actually Determines Your EBITDA Multiple

Understanding the multiple range is less important than understanding what moves your specific practice within that range. The following factors directly affect which multiple a buyer will apply.

Factors That Increase Your Multiple

Practice size and revenue scale. Larger practices command higher multiples. A practice generating $3M in collections with $800K in EBITDA will command a higher multiple than a practice generating $1M in collections with $200K in EBITDA — because the larger practice is more scalable, less dependent on a single provider, and more attractive as a platform for growth.

Strong and growing production trends. A practice with 10-15% year-over-year production growth tells a buyer the trajectory is favorable. Flat or declining production tells a buyer they're buying a mature or declining asset — and they'll price that risk into the multiple.

Hygiene production as a percentage of total. Buyers target 30%+ hygiene production as a proportion of total practice production. Strong hygiene production indicates a robust recall system, a loyal patient base, and a strong foundation for case presentation and restorative work. Practices below 20% hygiene production are often flagged for operational remediation.

Multiple producing providers. A practice where three or more providers contribute meaningfully to production is significantly more valuable than a practice where the owner is responsible for 80% of production. Provider concentration risk — the risk that production collapses if the primary provider leaves — is one of the most common valuation discount factors in dental transactions.

Favorable payer mix. A practice with a high proportion of PPO and fee-for-service patients commands better multiples than one with heavy Medicaid or HMO exposure. Medicaid reimbursement rates are typically well below market, suppressing both revenue and profitability. Heavy Medicaid or HMO exposure directly depresses valuation multiples.

Clean accounts receivable. AR over 90 days is flagged by every sophisticated buyer as a collection quality concern. A practice with 20% of its AR over 90 days is signaling collection process problems that will require remediation — and buyers will price that into the offer or make it a condition of closing.

Technology and digital infrastructure. Practices with digital radiography, digital impressions, and modern practice management software are viewed more favorably than those with analog systems. Analog X-rays are flagged as a capital expenditure requirement — buyers will discount for the cost of modernization.

Factors That Decrease Your Multiple

Single-provider concentration. If you are the primary producer, expect either a longer earnout structure, a lower multiple, or both. Buyers need confidence that production doesn't walk out the door when you transition out. The earnout — compensation tied to production performance post-close — is the buyer's mechanism for managing this risk.

Lease term and facility risk. PE buyers typically require 7-10 years of remaining lease term or options at the time of acquisition. A lease with two years remaining and no renewal option is a material obstacle to closing and will either require resolution before the transaction or be reflected in a price reduction.

Compliance gaps. HIPAA gaps, OSHA deficiencies, associate classification issues (1099 associates are a compliance red flag in many states), and billing irregularities all create indemnification exposure that sophisticated buyers will price into the deal. Gaps discovered in due diligence are far more expensive than gaps identified and remediated before going to market.

Deferred maintenance and capex needs. Equipment that needs replacement, facilities that need renovation, and technology that needs updating are all subtracted from the offer price. Buyers will estimate the cost of bringing the practice to their operational standard and reduce the offer accordingly.

Declining production or revenue. A practice with three consecutive years of declining production is signaling a fundamental problem — patient attrition, competitive pressure, provider quality issues, or market dynamics. Buyers discount heavily for adverse trends and may require significant earnout structures to share downside risk.

What Different Buyer Types Pay — and Why It Matters

The same dental practice can command materially different valuations from different buyer types. Understanding the buyer landscape is essential to pricing your practice correctly and choosing the right transaction structure.

Individual Dentist Buyers

Individual dentist buyers — typically associates or recently graduated dentists — are limited by their access to SBA financing and personal capital. SBA loans for dental practice acquisitions generally cap at $5M, limiting the transaction size. Individual buyers typically pay 0.7x to 0.9x annual collections or 4x to 5x EBITDA, and are most competitive for smaller, single-location practices below $1.5M in annual collections.

The advantage of selling to an individual buyer is simplicity — no rollover equity requirement, no earnout tied to corporate performance targets, and often a cleaner transition with more clinical autonomy preserved.

Regional DSO Buyers

Regional DSOs — organizations operating 10-50 locations within a defined geography — are active acquirers of practices that fit their geographic and clinical model. They typically pay 5x to 7x EBITDA and may offer equity participation in the regional platform as part of the transaction structure.

Regional DSOs bring operational infrastructure, group purchasing power, and marketing scale that can genuinely benefit the acquired practice — but they also bring integration requirements, operational standardization, and performance expectations that the selling dentist needs to understand before signing.

PE-Backed National DSO Buyers

Private equity-backed national DSOs are the most aggressive acquirers in today's market and typically offer the highest transaction values for practices that meet their acquisition criteria. They pay 6x to 9x EBITDA for platform-quality practices and may offer significant equity rollover — 10-30% of the deal value — that participates in the upside of the platform's growth and eventual exit.

The rollover equity structure is one of the most financially consequential decisions a selling dentist makes — and one of the least understood. Rolling 20% of a $3M transaction into equity that could be worth $1.5M or $0 depending on how the platform performs is a risk-return decision that requires financial modeling and legal counsel, not just a gut feel.

Unrepresented sellers negotiating directly with PE-backed DSOs routinely leave 20-40% of deal value on the table. The information asymmetry between a sophisticated institutional buyer and a dentist who has never sold a practice before is substantial.

The EBITDA Recast — Where Most Sellers Leave Money

The single most important financial step in preparing for a dental practice sale is understanding and documenting your recast EBITDA before buyers calculate it for you.

Recast EBITDA starts with your reported EBITDA and adds back:

• Owner compensation above market rate. If you're paying yourself $600,000 annually as an owner-dentist, a buyer will replace that with a market-rate dentist compensation of $200,000-$300,000. The $300,000+ difference adds back to EBITDA.
• Personal expenses run through the practice. Vehicle expenses, personal insurance, personal travel, and other personal expenses that appear on the practice P&L are added back as non-operating costs.
• One-time or non-recurring expenses. Significant one-time expenses — a major equipment purchase, a facility renovation, a legal dispute — that are unlikely to recur can be added back with appropriate documentation.
• Depreciation and amortization. Standard add-backs that normalize EBITDA across different accounting treatments.

The recast EBITDA is the number the buyer applies their multiple to. A practice with $500,000 in reported EBITDA but $800,000 in recast EBITDA, sold at a 6x multiple, is worth $4.8M — not $3M. That $1.8M difference is entirely a function of whether the seller understood and documented their add-backs before negotiations began.

Preparing Your Practice for Maximum Valuation

The actions that maximize valuation are not cosmetic — they are operational. The following improvements, implemented 12-24 months before going to market, consistently produce measurable valuation improvements.

• Reduce AR over 90 days to below 15% of total AR. This signals collection process discipline and removes a common buyer discount factor.
• Document your recast EBITDA with a dental CPA. This is not a DIY exercise — the add-backs need to be documented in a format that withstands buyer scrutiny.
• Reduce single-provider concentration. Adding an associate producer 12-18 months before a sale reduces provider concentration risk and demonstrates that production is not dependent on the selling dentist.
• Improve hygiene reappointment rate. Hygiene reappointment rate below 80% signals patient relationship fragility. Buyers evaluate recall systems as a leading indicator of long-term patient retention.
• Upgrade analog systems. Analog X-ray systems are consistently flagged as capital expenditure requirements. Upgrading to digital radiography before going to market eliminates this discount and signals operational modernity.
• Resolve compliance gaps. Engage a healthcare attorney to audit HIPAA compliance, OSHA documentation, and associate classification before buyers discover gaps in due diligence.
• Normalize lease terms. If your lease has fewer than 7 years remaining, initiate renewal negotiations before going to market. A lease with 10+ years of remaining term or options is a transaction facilitator, not an obstacle.

Common Valuation Mistakes That Cost Sellers Money

• Valuing the practice themselves using rules of thumb. "One times collections" is not a valuation — it is a starting point that ignores profitability, growth, risk, and market conditions. Practices that are valued using rules of thumb are almost always priced incorrectly.
• Approaching buyers without a dental-specific advisor. General business brokers do not have the relationships, market knowledge, or dental transaction experience to maximize value in a DSO or PE transaction. Dental-specific M&A advisors maintain ongoing relationships with active buyers and know current market pricing — both of which directly affect the transaction outcome.
• Negotiating rollover equity terms without financial modeling. The rollover equity ask from PE-backed buyers needs to be evaluated against financial projections for the platform, not accepted or rejected based on gut feel.
• Signing an LOI without understanding all terms. The letter of intent locks in key deal terms — purchase price, earnout structure, employment term, non-compete, rollover equity — before due diligence. Terms accepted at the LOI stage are extremely difficult to renegotiate after due diligence begins.
• Failing to disclose known issues. Issues discovered by buyers in due diligence are far more damaging to deal value than issues disclosed proactively. Transparency with documentation is the approach that protects value.

Working With Viturtal Consulting on Practice Valuation

Viturtal Consulting provides dental practice valuation support and transaction preparation advisory for practice owners preparing for a sale, merger, or DSO affiliation. Our approach is built on operational expertise — we understand what buyers are actually looking for, how they recast EBITDA, and what operational improvements produce the highest return in the pre-transaction window.

Our transaction preparation engagements typically begin 12-24 months before a planned sale and focus on the operational and financial improvements that maximize recast EBITDA and reduce the discount factors buyers apply to the valuation multiple.

For practice owners further from a transaction who want to understand their current valuation range, we offer a structured valuation assessment that produces a documented EBITDA recast, a current market multiple range, and a prioritized improvement roadmap.

Download our free Dental Practice Buyside Pre-Sale Checklist — a practical due diligence preparation guide covering the eight areas buyers scrutinize most closely in DSO transactions.

Contact Dr. Hendrik Lai at hendrik@viturtal.com or visit viturtal.com to schedule a consultation.